[
    {
        "text": "This episode was filmed on July 14th, 2020,",
        "start": 0.0,
        "duration": 2.82
    },
    {
        "text": "and if any big updates come out after our\nepisode,",
        "start": 2.83,
        "duration": 2.52
    },
    {
        "text": "we’ll include them in a pinned comment.",
        "start": 5.35,
        "duration": 1.16
    },
    {
        "text": "You can also find all our COVID-19-focused\nepisodes",
        "start": 6.51,
        "duration": 2.9
    },
    {
        "text": "in the playlist linked in the description.",
        "start": 9.41,
        "duration": 1.99
    },
    {
        "text": "[ intro ]",
        "start": 11.4,
        "duration": 2.36
    },
    {
        "text": "It’s well-known that the virus that causes\nCOVID-19",
        "start": 14.48,
        "duration": 2.5
    },
    {
        "text": "gets into human cells by taking advantage\nof a protein called ACE2.",
        "start": 16.98,
        "duration": 4.08
    },
    {
        "text": "But SARS-CoV-2 is a versatile virus,",
        "start": 21.06,
        "duration": 2.99
    },
    {
        "text": "and we’re still working to understand it.",
        "start": 24.05,
        "duration": 1.789
    },
    {
        "text": "Like, recent research suggests there’s at\nleast one more protein",
        "start": 25.839,
        "duration": 3.1
    },
    {
        "text": "it might use to get into cells.",
        "start": 28.939,
        "duration": 1.68
    },
    {
        "text": "If true, that might help us understand how\nthis viru",
        "start": 30.619,
        "duration": 2.681
    },
    {
        "text": "s is causing some of its stranger symptoms.",
        "start": 33.3,
        "duration": 2.23
    },
    {
        "text": "And, most importantly,",
        "start": 35.53,
        "duration": 1.38
    },
    {
        "text": "it might lead us towards new ways to help\npeople infected with it.",
        "start": 36.91,
        "duration": 3.22
    },
    {
        "text": "ACE2 is a cellular receptor—",
        "start": 40.13,
        "duration": 1.99
    },
    {
        "text": "a protein that juts out of cell membranes\nand binds to other molecules.",
        "start": 42.12,
        "duration": 4.38
    },
    {
        "text": "Receptors in general are a super important\npart of how cells interact with their environments.",
        "start": 46.5,
        "duration": 3.78
    },
    {
        "text": "But if a virus can bind to one of them,",
        "start": 50.28,
        "duration": 2.03
    },
    {
        "text": "it can often use the receptor to attach to\nthe cell’s membrane and get inside—",
        "start": 52.31,
        "duration": 4.51
    },
    {
        "text": "kind of like grabbing a doorknob lets you\nopen a door.",
        "start": 56.82,
        "duration": 2.2
    },
    {
        "text": "And there seems to be growing evidence",
        "start": 59.02,
        "duration": 1.44
    },
    {
        "text": "that this new coronavirus can grab at least\ntwo different doorknobs.",
        "start": 60.46,
        "duration": 4.0
    },
    {
        "text": "One we haven’t talked about yet is called",
        "start": 64.46,
        "duration": 1.93
    },
    {
        "text": "“cluster of differentiation 147”, or CD147\nfor short.",
        "start": 66.39,
        "duration": 3.899
    },
    {
        "text": "Actually, it has lots of names: EMMPRIN, M6,\nBasigin",
        "start": 70.289,
        "duration": 3.74
    },
    {
        "text": "… but they’re all the same basic protein.",
        "start": 74.029,
        "duration": 2.921
    },
    {
        "text": "One of CD147’s most common jobs",
        "start": 76.95,
        "duration": 1.61
    },
    {
        "text": "is facilitating communication between cells\nas they coordinate tasks.",
        "start": 78.56,
        "duration": 4.009
    },
    {
        "text": "So, it’s found on a bunch of different kinds\nof cells all over the body,",
        "start": 82.569,
        "duration": 3.61
    },
    {
        "text": "and it has its molecular hands in lots of\nphysiological pots, so to speak.",
        "start": 86.179,
        "duration": 4.11
    },
    {
        "text": "Now, there are a number of viruses that use\nCD147 to infect cells,",
        "start": 90.289,
        "duration": 4.43
    },
    {
        "text": "including HIV and measles.",
        "start": 94.719,
        "duration": 1.61
    },
    {
        "text": "The original SARS virus seemed to have this\nability, too.",
        "start": 96.329,
        "duration": 2.68
    },
    {
        "text": "And, a study put online in March 2020 suggests",
        "start": 99.009,
        "duration": 2.74
    },
    {
        "text": "that SARS-CoV-2 is following in its footsteps.",
        "start": 101.749,
        "duration": 2.86
    },
    {
        "text": "In that study, researchers found that CD147\ncan bind to the virus’s spike proteins—",
        "start": 104.609,
        "duration": 5.04
    },
    {
        "text": "those, well, spikey proteins on the outside\nof coronaviruses.",
        "start": 109.649,
        "duration": 3.091
    },
    {
        "text": "They’re the part that binds to ACE2, so\nthat makes sense.",
        "start": 112.74,
        "duration": 3.399
    },
    {
        "text": "And though the study isn’t peer-reviewed\nyet,",
        "start": 116.139,
        "duration": 2.37
    },
    {
        "text": "virologists seem to be taking the results\nand their implications seriously.",
        "start": 118.509,
        "duration": 3.68
    },
    {
        "text": "If SARS-CoV-2 is using CD147 as an alternate\nroute into cells,",
        "start": 122.189,
        "duration": 4.981
    },
    {
        "text": "that might help us understand some of the\npeculiar traits of COVID-19—",
        "start": 127.17,
        "duration": 3.25
    },
    {
        "text": "like its relationship with type 2 diabetes.",
        "start": 130.42,
        "duration": 2.48
    },
    {
        "text": "See, a 2010 study found that high blood sugar\nincreases the body’s production of CD147.",
        "start": 132.9,
        "duration": 4.86
    },
    {
        "text": "So, if the virus can use this receptor to\nget into cells,",
        "start": 137.76,
        "duration": 3.31
    },
    {
        "text": "then people with higher blood sugar may be\nmore susceptible to infection.",
        "start": 141.07,
        "duration": 3.74
    },
    {
        "text": "And people with diabetes tend to have higher\nblood sugar.",
        "start": 144.81,
        "duration": 2.94
    },
    {
        "text": "That could explain the results of a paper\nfrom June,",
        "start": 147.75,
        "duration": 2.48
    },
    {
        "text": "which found that people with type 2 diabetes\nare more likely to get severe COVID-19 symptoms.",
        "start": 150.23,
        "duration": 4.52
    },
    {
        "text": "And diabetes might not be the only condition\nto watch out for.",
        "start": 154.75,
        "duration": 3.62
    },
    {
        "text": "Researchers in a June paper looked to see",
        "start": 158.37,
        "duration": 1.41
    },
    {
        "text": "where the known and potential receptors for\nthis virus are in the body,",
        "start": 159.78,
        "duration": 4.22
    },
    {
        "text": "and how that changes with disease.",
        "start": 164.0,
        "duration": 1.84
    },
    {
        "text": "They included ACE2, CD147 and another receptor,",
        "start": 165.84,
        "duration": 3.54
    },
    {
        "text": "called CD26, that some have suggested may\nalso be used.",
        "start": 169.38,
        "duration": 4.05
    },
    {
        "text": "And it turns out they’re all over the place.",
        "start": 173.43,
        "duration": 2.01
    },
    {
        "text": "And CD147 in particular is more common in\nconditions like",
        "start": 175.44,
        "duration": 3.54
    },
    {
        "text": "asthma, obesity, COPD, and hypertension.",
        "start": 178.98,
        "duration": 3.47
    },
    {
        "text": "It may even tie in to some skin rashes associated\nwith COVID-19!",
        "start": 182.45,
        "duration": 3.36
    },
    {
        "text": "Another, kind-of-odd symptom of some COVID-19\ninfections",
        "start": 185.81,
        "duration": 3.24
    },
    {
        "text": "that might relate to CD147 is excessive blood\nclotting.",
        "start": 189.05,
        "duration": 4.01
    },
    {
        "text": "Now, blood clots can be caused by a variety\nof things,",
        "start": 193.06,
        "duration": 2.79
    },
    {
        "text": "including inflammation and damaged blood vessels.",
        "start": 195.85,
        "duration": 2.58
    },
    {
        "text": "But they can also be caused by antibodies.",
        "start": 198.43,
        "duration": 2.33
    },
    {
        "text": "See, if a virus attaches to red blood cells,",
        "start": 200.76,
        "duration": 2.51
    },
    {
        "text": "the immune system will send antibodies to\nattack it.",
        "start": 203.27,
        "duration": 2.72
    },
    {
        "text": "And if lots of those antibodies end up stuck\nonto viruses",
        "start": 205.99,
        "duration": 2.63
    },
    {
        "text": "that are attached to red blood cells,",
        "start": 208.62,
        "duration": 2.17
    },
    {
        "text": "they can make the cells kind of “sticky”\nand cause clots.",
        "start": 210.79,
        "duration": 2.78
    },
    {
        "text": "While red blood cells don’t have ACE2 on\nthem,",
        "start": 213.57,
        "duration": 2.89
    },
    {
        "text": "they do have CD147.",
        "start": 216.46,
        "duration": 1.34
    },
    {
        "text": "In fact, it’s the receptor that malaria\nparasites use to get inside them.",
        "start": 217.8,
        "duration": 4.73
    },
    {
        "text": "So, if SARS-CoV-2 also binds to CD147,",
        "start": 222.53,
        "duration": 3.21
    },
    {
        "text": "that might help explain patients’ excessive\nclotting.",
        "start": 225.74,
        "duration": 2.71
    },
    {
        "text": "Plus, CD147 is found in endothelial cells:",
        "start": 228.45,
        "duration": 3.23
    },
    {
        "text": "the cells that line the inside walls of blood\nvessels.",
        "start": 231.68,
        "duration": 2.89
    },
    {
        "text": "If the receptor is helping the virus infect\nthose cells directly,",
        "start": 234.57,
        "duration": 3.42
    },
    {
        "text": "that could further explain the clotting as\nwell as other cardiovascular effects of COVID-19,",
        "start": 237.99,
        "duration": 4.7
    },
    {
        "text": "like high blood pressure.",
        "start": 242.69,
        "duration": 1.22
    },
    {
        "text": "All of that might sound scary,",
        "start": 243.91,
        "duration": 1.48
    },
    {
        "text": "but understanding how COVID-19 interacts with\nother health conditions",
        "start": 245.39,
        "duration": 3.39
    },
    {
        "text": "is an important step in figuring out how best\nto treat patients.",
        "start": 248.78,
        "duration": 3.12
    },
    {
        "text": "And CD147 doesn’t just help explain COVID-19’s\nawful effects.",
        "start": 251.9,
        "duration": 4.22
    },
    {
        "text": "It might also lead us towards better treatments\nfor them.",
        "start": 256.12,
        "duration": 2.44
    },
    {
        "text": "See, in that preprint paper from March,",
        "start": 258.56,
        "duration": 2.56
    },
    {
        "text": "researchers also reported that a laboratory-designed\nantibody called Meplazumab",
        "start": 261.12,
        "duration": 4.47
    },
    {
        "text": "seems to stop the SARS-CoV-2 virus from infecting\ncells.",
        "start": 265.59,
        "duration": 3.4
    },
    {
        "text": "It was designed to glom onto CD147 and prevent\nthings from binding to it.",
        "start": 268.99,
        "duration": 4.58
    },
    {
        "text": "So, it may essentially take away many of the\nvirus’s doorknobs, and therefore,",
        "start": 273.57,
        "duration": 3.84
    },
    {
        "text": "reduce the overall impact the infection has\non the body.",
        "start": 277.41,
        "duration": 2.96
    },
    {
        "text": "And a separate trial of 17 COVID-19 patients\nin a Chinese hospital found exactly that—",
        "start": 280.37,
        "duration": 5.62
    },
    {
        "text": "their conditions improved when treated with\nMeplazumab.",
        "start": 285.99,
        "duration": 2.34
    },
    {
        "text": "That’s a super small study, of course,",
        "start": 288.33,
        "duration": 2.0
    },
    {
        "text": "and it also still needs to be peer-reviewed.",
        "start": 290.33,
        "duration": 2.01
    },
    {
        "text": "So, we should take the findings with a grain\nof salt.",
        "start": 292.34,
        "duration": 2.59
    },
    {
        "text": "Plus, the antibody isn’t actually approved\nfor human use yet,",
        "start": 294.93,
        "duration": 3.08
    },
    {
        "text": "so we’d need to make sure it’s safe, too.",
        "start": 298.01,
        "duration": 2.68
    },
    {
        "text": "Researchers have also been looking at a drug\ncalled azithromycin.",
        "start": 300.69,
        "duration": 2.41
    },
    {
        "text": "It’s an antibiotic used against certain\nbacterial infections,",
        "start": 303.1,
        "duration": 3.75
    },
    {
        "text": "but it’s also used to treat malaria—",
        "start": 306.85,
        "duration": 2.18
    },
    {
        "text": "in part because it seems to block the parasites\nfrom using CD147 to get into blood cells.",
        "start": 309.03,
        "duration": 4.75
    },
    {
        "text": "So, it might be able to block SARS-CoV-2 from\ninfecting cells the same way.",
        "start": 313.78,
        "duration": 4.58
    },
    {
        "text": "But we’ll need to see that happen in high-quality\nresearch before we get too excited.",
        "start": 318.36,
        "duration": 3.89
    },
    {
        "text": "And, it’s entirely possible neither of these\nwill pan out—",
        "start": 322.25,
        "duration": 2.88
    },
    {
        "text": "or, more generally, that CD147 isn’t that\nimportant to the virus after all.",
        "start": 325.13,
        "duration": 4.57
    },
    {
        "text": "This is what it looks like for scientific\nresearch to happen in real time!",
        "start": 329.7,
        "duration": 3.61
    },
    {
        "text": "We’re getting a lot of new information about\nthis virus every day,",
        "start": 333.31,
        "duration": 2.98
    },
    {
        "text": "and some of it will inevitably prove less\nhelpful than others.",
        "start": 336.29,
        "duration": 2.87
    },
    {
        "text": "Still, it’s important for scientists to\ncontinue to study CD147 and any other potential",
        "start": 339.16,
        "duration": 4.68
    },
    {
        "text": "doorknobs the virus may be using,",
        "start": 343.84,
        "duration": 2.09
    },
    {
        "text": "because knowing exactly how it can get into\ncells",
        "start": 345.93,
        "duration": 2.02
    },
    {
        "text": "can help scientists figure out the best ways\nto slow it down or stop it.",
        "start": 347.95,
        "duration": 4.23
    },
    {
        "text": "Thanks for watching this episode of SciShow\nNews!",
        "start": 352.18,
        "duration": 2.09
    },
    {
        "text": "And thanks to all our patrons on Patreon",
        "start": 354.27,
        "duration": 1.97
    },
    {
        "text": "who make it possible for us to cover tricky,\nquick-paced topics like this one.",
        "start": 356.24,
        "duration": 3.72
    },
    {
        "text": "If you want to learn more about our Patreon\ncommunity,",
        "start": 359.96,
        "duration": 1.959
    },
    {
        "text": "you can head on over to Patreon.com/SciShow.",
        "start": 361.919,
        "duration": 1.72
    },
    {
        "text": "And if there’s anything else about COVID-19\nthat you want to learn more about,",
        "start": 363.639,
        "duration": 4.621
    },
    {
        "text": "let us know in the comments.",
        "start": 368.26,
        "duration": 1.0
    },
    {
        "text": "[ outro ]",
        "start": 369.26,
        "duration": 7.8
    }
]